Literature DB >> 29909093

The DaXa-inhibition assay: A concept for a readily available, universal aXa assay that measures the direct inhibitory effect of all anti-Xa drugs.

L Joost van Pelt1, Michaël V Lukens2, Sophie Testa3, Bernard Chatelain4, Jonathan Douxfils5, Francois Mullier4.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29909093     DOI： 10.1016/j.thromres.2018.04.024

Source DB:  PubMed          Journal:  Thromb Res        ISSN： 0049-3848            Impact factor:   3.944


× No keyword cloud information.
  7 in total

1.  Direct oral anticoagulant monitoring: what laboratory tests are available to guide us?

Authors:  Ravi Sarode
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2019-12-06

2.  Monitoring of Anticoagulant Activity of Dabigatran and Rivaroxaban in the Presence of Heparins.

Authors:  Aleksandra Jakimczuk; Bartlomiej Kalaska; Kamil Kamiński; Joanna Miklosz; Shin-Ichi Yusa; Dariusz Pawlak; Krzysztof Szczubiałka; Andrzej Mogielnicki
Journal:  J Clin Med       Date:  2022-04-16       Impact factor: 4.964

3.  The edoxaban-M4 metabolite and measurement of edoxaban by chromogenic assays in human plasma.

Authors:  Romain Siriez; Halil Yildiz; Céline Bouvy; Hélène Haguet; Vincent Maloteau; Michaël Hardy; François Mullier; Jean-Michel Dogné; Philippe Hainaut; Jonathan Douxfils
Journal:  Res Pract Thromb Haemost       Date:  2022-04-11

4.  International Normalized Ratio as a Screening Test for Assessment of Anticoagulant Activity for Patients Treated With Rivaroxaban or Apixaban: A Pilot Study.

Authors:  Fanny Ofek; Dana Barchel; Nofar Perets; Tomer Ziv-Baran; Ahmad Mahajna; Talia Filipovich-Rimon; Osnat Garach-Jehoshua; Maya Berlin; Matitiahu Berkovitch
Journal:  Front Pharmacol       Date:  2019-10-08       Impact factor: 5.810

5.  An in vitro study to investigate the interference of enoxaparin on plasma levels of direct oral factor Xa inhibitors measured by chromogenic assays.

Authors:  Michela Cini; Cristina Legnani; Sophie Testa; Armando Tripodi; Benilde Cosmi; Gualtiero Palareti
Journal:  Int J Lab Hematol       Date:  2019-01-30       Impact factor: 2.877

6.  Accuracy of a Single, Heparin-Calibrated Anti-Xa Assay for the Measurement of Rivaroxaban, Apixaban, and Edoxaban Drug Concentrations: A Prospective Cross-Sectional Study.

Authors:  Tamana Meihandoest; Jan-Dirk Studt; Adriana Mendez; Lorenzo Alberio; Pierre Fontana; Walter A Wuillemin; Adrian Schmidt; Lukas Graf; Bernhard Gerber; Ursula Amstutz; Cedric Bovet; Thomas C Sauter; Lars M Asmis; Michael Nagler
Journal:  Front Cardiovasc Med       Date:  2022-03-17

7.  Chromogenic anti-FXa assay calibrated with low molecular weight heparin in patients treated with rivaroxaban and apixaban: possibilities and limitations.

Authors:  Sandra Margetić; Ivana Ćelap; Diana Delić Brkljačić; Nikola Pavlović; Sandra Šupraha Goreta; Ivana Kobasić; Arijana Lovrenčić-Huzjan; Vanja Bašić Kes
Journal:  Biochem Med (Zagreb)       Date:  2019-12-15       Impact factor: 2.313
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.